ResMed Inc. announced that its board of directors has appointed chief executive officer Michael (Mick) Farrell as chair of the board, effective January 25, 2023. Mr. Farrell succeeds current chair Peter Farrell who will become chair emeritus and will remain an active board member. Mick Farrell became ResMed's CEO on March 1, 2013, and has served as a member of the company's board of directors since assuming that role.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
194.7 USD | +2.82% |
|
+1.73% | +13.21% |
01/07 | ResMed Inc.(NYSE:RMD) added to Russell 1000 Dynamic Index | CI |
01/07 | ResMed Inc.(NYSE:RMD) added to Russell Midcap Value Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.21% | 2.86TCr | |
+1.75% | 21TCr | |
+3.42% | 18TCr | |
+31.54% | 16TCr | |
+32.16% | 11TCr | |
+2.36% | 6.46TCr | |
+21.08% | 5.56TCr | |
-1.61% | 4.76TCr | |
-9.11% | 3.69TCr | |
-0.34% | 3.52TCr |
- Stock Market
- Equities
- RMD Stock
- News ResMed, Inc.
- ResMed Inc. Announces Board Changes